Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/17/2/246/391625/mdj041.pdf
Reference39 articles.
1. Swedish Rectal Cancer Trial. Improved survival with preoperative radiation in resectable rectal cancer;N Engl J Med,1997
2. Dutch Colorectal Cancer Group: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001
3. Adjuvant therapy of rectal cancer;Minsky;Semin Oncol,1999
4. Effective surgical adjuvant therapy for high-risk rectal carcinoma;Krook;N Engl J Med,1991
5. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01;Fisher;J Natl Cancer Inst,1988
Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rektum Kanseri Tanısıyla Radyoterapi ile Eş Zamanlı 5-Florourasil/Kapesitabin Uygulanan Hastaların 10 Yıllık Sağkalımına Etki Eden Faktörlerin Retrospektif Değerlendirilmesi;Akdeniz Medical Journal;2023-06-13
2. Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD;Journal of Clinical Oncology;2021-01-01
3. Chemoradiotherapy for Locally Advanced T3/T4 Rectal Cancer: What Should We Do with Complete Responders?;Multidisciplinary Treatment of Colorectal Cancer;2020-11-17
4. Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center;Therapeutic Advances in Medical Oncology;2020-01
5. Additional Chemotherapy with 5-FU plus Leucovorin between Preoperative Chemoradiotherapy and Surgery Improved Treatment Outcomes in Patients with Advanced Rectal Cancer;Journal of Cancer;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3